Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. GeneTerpret: a customizable multilayer approach to genomic variant prioritization and interpretation
This is not the latest version of this item. The latest version can be found here.

GeneTerpret: a customizable multilayer approach to genomic variant prioritization and interpretation

Thumbnail Image
Download
Name

12920_2022_Article_1166.pdf

Size

2.21 MB

Format

Adobe PDF

Checksum (MD5)

c323d44f15f2b4f7e62a3f3e60363158

Download all files submitted through automated deposit
art_5296036656791478989.zip (1.96 MB)
Author(s)
Manshaei, Roozbeh
•
DeLong, Sean
•
Andric, Veronica
•
Joshi, Esha
•
Okello, John B. A.
•
Dhir, Priya
•
Somerville, Cherith
•
Farncombe, Kirsten M.
•
Kalbfleisch, Kelsey
•
Jobling, Rebekah K.
more
Date Issued
February 18, 2022
Publisher
BioMed Central
Citation
BMC Medical Genomics. 2022 Feb 18;15(1):31
Version
Final published version
Abstract
Abstract Background Variant interpretation is the main bottleneck in medical genomic sequencing efforts. This usually involves genome analysts manually searching through a multitude of independent databases, often with the aid of several, mostly independent, computational tools. To streamline variant interpretation, we developed the GeneTerpret platform which collates data from current interpretation tools and databases, and applies a phenotype-driven query to categorize the variants identified in the genome(s). The platform assigns quantitative validity scores to genes by query and assembly of the genotype–phenotype data, sequence homology, molecular interactions, expression data, and animal models. It also uses the American College of Medical Genetics and Genomics (ACMG) criteria to categorize variants into five tiers of pathogenicity. The final output is a prioritized list of potentially causal variants/genes. Results We tested GeneTerpret by comparing its performance to expert-curated genes (ClinGen’s gene-validity database) and variant pathogenicity reports (DECIPHER database). Output from GeneTerpret was 97.2% and 83.5% concordant with the expert-curated sources, respectively. Additionally, similar concordance was observed when GeneTerpret’s performance was compared with our internal expert-interpreted clinical datasets. Conclusions GeneTerpret is a flexible platform designed to streamline the genome interpretation process, through a unique interface, with improved ease, speed and accuracy. This modular and customizable system allows the user to tailor the component-programs in the analysis process to their preference. GeneTerpret is available online at https://geneterpret.com .
Terms of Use
Creative Commons Attribution
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/140551
DOI of Published Version
https://doi.org/10.1186/s12920-022-01166-3
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.